OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
68 hedge funds and large institutions have $65.1M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $222K
Holders
68
Holding in Top 10
1
Calls
$1K
Puts
$222K
Top Buyers
| 1 | +$12.1M | |
| 2 | +$8.79M | |
| 3 | +$954K | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$561K |
| 5 |
Two Sigma Investments
New York
|
+$439K |
Top Sellers
| 1 | -$9.08M | |
| 2 | -$8.88M | |
| 3 | -$3.04M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.14M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$651K |